AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $194,560 | -80.3% | 16,000 | -84.0% | 0.00% | -80.0% |
| Q1 2021 | $988,000 | -96.6% | 100,000 | -92.0% | 0.01% | -97.1% |
| Q4 2020 | $28,863,000 | -49.4% | 1,250,000 | -65.8% | 0.17% | -50.7% |
| Q2 2018 | $57,091,000 | +9.0% | 3,655,000 | +5.0% | 0.35% | -2.8% |
| Q1 2018 | $52,354,000 | +30.8% | 3,481,000 | +25.2% | 0.36% | +11.7% |
| Q4 2017 | $40,019,000 | -47.8% | 2,781,000 | -45.3% | 0.32% | -52.3% |
| Q3 2017 | $76,622,000 | +153.6% | 5,081,055 | +69.4% | 0.68% | +116.9% |
| Q2 2017 | $30,210,000 | – | 3,000,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |